• Written by: (Investorideas.com newswire, breaking stock market
  • Thu, 19 Sep 2024
  •   United States

September 19, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of cancer and solid tumors focusing on immunotherapy, featuring Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening viral infections.

Immunotherapy Clinical Trial News - Stocks to Watch